CPIX - CIK 0001087294
The table below shows CUMBERLAND PHARMACEUTICALS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.44M | $17.96M | $18.32M | $19.76M | $27.04M | $24.75M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $16.94M | $11.70M | $9.76M | $13.16M | $6.88M | $12.38M |
| Inventory | $6.23M | $4.00M | $4.61M | $9.86M | $8.43M | $10.64M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $37.06M |
| $36.45M |
| $35.71M |
| $45.87M |
| $45.69M |
| $49.97M |
| Property, plant & equipment | $264.72K | $277.37K | $367.90K | $284.04K | $442.63K | $574.17K |
| Goodwill | $914.00K | $914.00K | $914.00K | $914.00K | $882.00K | $882.00K |
| Total assets | $76.82M | $75.58M | $81.78M | $92.93M | $84.46M | $96.46M |
| Accounts payable | $18.57M | $13.91M | $14.04M | $10.82M | $9.64M | $13.40M |
| Total current liabilities | $36.74M | $31.62M | $27.98M | $28.58M | $19.28M | $25.67M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $52.28M | $53.04M | $52.52M | $56.95M | $41.86M | $49.59M |
| Retained earnings | -$26.80M | -$23.97M | -$17.49M | -$11.21M | -$5.64M | -$2.13M |
| Total equity | $24.88M | $22.85M | $29.60M | $36.27M | $42.81M | $46.99M |